162 related articles for article (PubMed ID: 15262144)
1. Association between uterine serous carcinoma and breast cancer.
Gehrig PA; Bae-Jump VL; Boggess JF; Groben PA; Fowler WC; Van Le L
Gynecol Oncol; 2004 Jul; 94(1):208-11. PubMed ID: 15262144
[TBL] [Abstract][Full Text] [Related]
2. Relationship between tamoxifen use and high risk endometrial cancer histologic types.
Bland AE; Calingaert B; Secord AA; Lee PS; Valea FA; Berchuck A; Soper JT; Havrilesky L
Gynecol Oncol; 2009 Jan; 112(1):150-4. PubMed ID: 18937966
[TBL] [Abstract][Full Text] [Related]
3. Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?
Slomovitz BM; Sun CC; Ramirez PT; Bodurka DC; Diaz P; Lu KH
Obstet Gynecol; 2004 Aug; 104(2):255-60. PubMed ID: 15291996
[TBL] [Abstract][Full Text] [Related]
4. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
[TBL] [Abstract][Full Text] [Related]
5. Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?
Boruta DM; Gehrig PA; Groben PA; Bae-Jump V; Boggess JF; Fowler WC; Van Le L
Cancer; 2004 Nov; 101(10):2214-21. PubMed ID: 15452833
[TBL] [Abstract][Full Text] [Related]
6. Radiation-associated endometrial cancers are prognostically unfavorable tumors: a clinicopathologic comparison with 527 sporadic endometrial cancers.
Pothuri B; Ramondetta L; Eifel P; Deavers MT; Wilton A; Alektiar K; Barakat R; Soslow RA
Gynecol Oncol; 2006 Dec; 103(3):948-51. PubMed ID: 16870239
[TBL] [Abstract][Full Text] [Related]
7. Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use.
Cuenca RE; Giachino J; Arredondo MA; Hempling R; Edge SB
Cancer; 1996 May; 77(10):2058-63. PubMed ID: 8640670
[TBL] [Abstract][Full Text] [Related]
8. Comparison of uterine malignancies that develop during and following tamoxifen therapy.
Ferguson SE; Soslow RA; Amsterdam A; Barakat RR
Gynecol Oncol; 2006 May; 101(2):322-6. PubMed ID: 16352333
[TBL] [Abstract][Full Text] [Related]
9. Papillary serous carcinoma of the uterus: increased risk of subsequent or concurrent development of breast carcinoma.
Geisler JP; Sorosky JI; Duong HL; Buekers TE; Geisler MJ; Sood AK; Anderson B; Buller RE
Gynecol Oncol; 2001 Dec; 83(3):501-3. PubMed ID: 11733962
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
Swerdlow AJ; Jones ME;
J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
[TBL] [Abstract][Full Text] [Related]
11. Endometrial carcinoma in elderly women.
Hoffman K; Nekhlyudov L; Deligdisch L
Gynecol Oncol; 1995 Aug; 58(2):198-201. PubMed ID: 7622105
[TBL] [Abstract][Full Text] [Related]
12. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
Giordano G; Gnetti L; Merisio C; Melpignano M
Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
[TBL] [Abstract][Full Text] [Related]
13. The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer.
Lachance JA; Everett EN; Greer B; Mandel L; Swisher E; Tamimi H; Goff B
Gynecol Oncol; 2006 Jun; 101(3):470-5. PubMed ID: 16413048
[TBL] [Abstract][Full Text] [Related]
14. Outcomes in patients with primary breast cancer and a subsequent diagnosis of endometrial cancer : comparison of cohorts treated with and without tamoxifen.
Saadat M; Truong PT; Kader HA; Speers CH; Berthelet E; McMurtrie E; Olivotto IA
Cancer; 2007 Jul; 110(1):31-7. PubMed ID: 17510927
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic review of malignant polyps in stage 1A carcinoma of the endometrium.
Farrell R; Scurry J; Otton G; Hacker NF
Gynecol Oncol; 2005 Aug; 98(2):254-62. PubMed ID: 15936803
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer.
Hoogendoorn WE; Hollema H; van Boven HH; Bergman E; de Leeuw-Mantel G; Platteel I; Fles R; Nederlof PM; Mourits MJ; van Leeuwen FE;
Breast Cancer Res Treat; 2008 Nov; 112(1):99-108. PubMed ID: 18064567
[TBL] [Abstract][Full Text] [Related]
17. Endometrioid epithelial ovarian cancer : 20 years of prospectively collected data from a single center.
Storey DJ; Rush R; Stewart M; Rye T; Al-Nafussi A; Williams AR; Smyth JF; Gabra H
Cancer; 2008 May; 112(10):2211-20. PubMed ID: 18344211
[TBL] [Abstract][Full Text] [Related]
18. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.
Soliman PT; Slomovitz BM; Broaddus RR; Sun CC; Oh JC; Eifel PJ; Gershenson DM; Lu KH
Gynecol Oncol; 2004 Aug; 94(2):456-62. PubMed ID: 15297188
[TBL] [Abstract][Full Text] [Related]
19. Role of body mass index as a risk and prognostic factor of endometrioid uterine cancer in Korean women.
Jeong NH; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Seo SS; Park CY; Kim KT; Lee J
Gynecol Oncol; 2010 Jul; 118(1):24-8. PubMed ID: 20400173
[TBL] [Abstract][Full Text] [Related]
20. Is tamoxifen associated with high-risk endometrial carcinomas? A retrospective case series of 196 women with endometrial cancer.
Rieck GC; Freites ON; Williams S
J Obstet Gynaecol; 2005 Jan; 25(1):39-41. PubMed ID: 16147692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]